BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20004647)

  • 1. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis.
    Min SH; Wang Y; Gonsiorek W; Anilkumar G; Kozlowski J; Lundell D; Fine JS; Grant EP
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1080-6. PubMed ID: 20004647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
    Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
    Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
    Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
    J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice.
    Mihara K; Smit MJ; Krajnc-Franken M; Gossen J; Rooseboom M; Dokter W
    Eur J Immunol; 2005 Sep; 35(9):2573-82. PubMed ID: 16094689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
    Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
    Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
    Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
    Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis.
    Brühl H; Cihak J; Plachý J; Kunz-Schughart L; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Luckow B; Stangassinger M; Mack M
    Arthritis Rheum; 2007 Sep; 56(9):2975-85. PubMed ID: 17763443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
    Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.
    Vergunst CE; Gerlag DM; Lopatinskaya L; Klareskog L; Smith MD; van den Bosch F; Dinant HJ; Lee Y; Wyant T; Jacobson EW; Baeten D; Tak PP
    Arthritis Rheum; 2008 Jul; 58(7):1931-9. PubMed ID: 18576354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies.
    Tanaka K; Yoshitomi T; Hirahara K
    Biol Pharm Bull; 2017; 40(5):729-732. PubMed ID: 28458362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
    Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
    J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain.
    Carreira EU; Carregaro V; Teixeira MM; Moriconi A; Aramini A; Verri WA; Ferreira SH; Cunha FQ; Cunha TM
    Eur J Pain; 2013 May; 17(5):654-63. PubMed ID: 23132735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.
    Henke PK; Varga A; De S; Deatrick CB; Eliason J; Arenberg DA; Sukheepod P; Thanaporn P; Kunkel SL; Upchurch GR; Wakefield TW
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1130-7. PubMed ID: 15105284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.
    Rafei M; Berchiche YA; Birman E; Boivin MN; Young YK; Wu JH; Heveker N; Galipeau J
    J Immunol; 2009 Aug; 183(3):1759-66. PubMed ID: 19592643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.